Guide · Updated November 2026

Why Your Employer Won’t Cover GLP-1s (and What Helps)

Q: Can I appeal my employer's decision to exclude GLP-1s from coverage?

Not through a clinical appeal. A plan exclusion is a benefit design decision made by your plan sponsor, and it isn't something a doctor's letter of medical necessity can override. The main lever is raising it with HR ahead of the next plan-year renewal.

Q: Does my state's GLP-1 coverage law apply to my employer's plan?

Probably not. The only state mandate we found, North Dakota's, applies to individual and small-group plans, and federal ERISA law generally exempts self-funded employer plans from state insurance mandates where they do exist.

Q: How do I know if my plan is self-funded?

Ask HR directly or check your plan's summary plan description for funding language. A familiar insurer's name on your card doesn't tell you this, since insurers administer both fully insured and self-funded plans.

Q: Is it worth bringing up weight-based discrimination law with my employer?

It's worth knowing it exists, but it's an unsettled legal area, not an established right to coverage. A few states and cities have weight-based non-discrimination laws that attorneys have flagged as a theoretical risk, not a guaranteed remedy.

If your plan flatly excludes GLP-1 medications for weight loss, a prior authorization appeal won't fix that. An exclusion and a coverage restriction are two different problems with two different fixes, and for most large-employer workers, the reason goes back to how the plan is funded, not what your state law says.

Self-funded vs. fully insured: the distinction that actually matters

A fully insured plan is one where your employer pays premiums to an insurance company, and that insurer carries the financial risk and has to follow your state’s insurance laws, including any state mandate on drug coverage.

A self-funded (also called self-insured) plan is different. Your employer pays claims directly out of its own funds and just hires an administrator, often a familiar insurer brand, to process claims and manage the network. Because the employer is the one bearing the risk, these plans fall under the federal ERISA law, which generally preempts state insurance mandates from reaching them.

According to KFF’s 2025 Employer Health Benefits Survey, 67% of covered workers nationally are in self-funded plans, and that share is far higher at bigger employers: 80% of covered workers at larger firms are in self-funded plans, versus 27% at firms with 10 to 199 workers (where another 37% are in a hybrid level-funded arrangement). If you work for a large employer, there’s a good chance your plan is self-funded whether or not the card in your wallet says a familiar insurer’s name.

Already know your plan excludes it?

See Current Cash-Pay Prices →

Only one state mandate exists, and it skips large employers

It’s tempting to assume a state mandate protects you if you don’t work for a self-funded employer. For most people, that protection doesn’t exist either way.

The clearest state requirement we found is North Dakota’s, and it’s narrower than the headlines suggest. North Dakota’s insurance department says GLP-1 and GIP weight-loss drugs became an essential health benefit for qualifying individual and small-group plans that begin on or after January 1, 2025. The change does not apply to grandfathered or large-group plans, and state mandates generally don’t reach self-funded plans.

Some states run their own state-employee health plans, and some have gone the opposite direction. North Carolina’s State Health Plan dropped GLP-1 weight-loss coverage in 2024 over cost. In March 2025, its treasurer asked lawmakers for $100 million to bring coverage back for a narrower group of members. Check the plan’s current rules if this applies to you.

There’s a separate, less direct source of pressure worth knowing about: employment discrimination law. New York City banned employment discrimination based on weight and height from November 22, 2023, joining two states (Michigan and Washington) and six cities, including San Francisco, with similar bans. Whether any of these laws affect a health plan’s drug exclusion is an open legal question, not a settled right you can invoke to force coverage, so don’t treat it as a guaranteed path.

Exclusion vs. exception: know which problem you have

Before you do anything else, find out which of these two things is actually happening, because they call for completely different responses.

Your situation	What it means	What can fix it
Plan document says anti-obesity medications are categorically excluded	This is a benefit design decision made by whoever sponsors the plan (your employer, for a self-funded plan)	Only a future plan-year change can add the benefit. A clinical appeal can’t override an exclusion.
Plan covers GLP-1s but requires prior authorization, step therapy, or a specific diagnosis	This is a coverage restriction, not an exclusion	A formulary exception or appeal through your plan’s standard process can work. See our insurance coverage guide for the appeal steps.

Ask your HR or benefits team this exact question: “Does our plan’s summary plan description categorically exclude anti-obesity medications, or does it cover them with restrictions?” That’s different from asking “does insurance cover Ozempic,” which can get you a vague or wrong answer from someone who doesn’t know the distinction.

Employer coverage is moving in both directions at once

Survey data on whether employers cover GLP-1s for weight loss varies a lot depending on who’s asking and who they’re asking. Business Group on Health, a membership organization of large employers, found 67% of the 105 employers it surveyed in February and March 2026 cover GLP-1s for weight management. KFF’s 2025 survey found 19% of firms with 200 or more workers cover GLP-1s for weight loss, rising to 43% among firms with 5,000 or more workers (up from 28% in 2024). Those numbers aren’t contradictory so much as describing different populations: KFF surveys a wide range of employer sizes, while Business Group on Health’s membership skews toward the largest, most benefits-generous employers.

The trend for 2027 is mixed. In the Business Group on Health survey, 72% of employers that cover the drugs said they were likely to keep coverage in 2027 and 10% said they likely would not. Mercer reported in June 2026 that 6% of large employers dropped coverage in 2026 and another 5% plan to drop it in 2027 or are considering it. Those two numbers measure different groups, so they don’t conflict. It has already happened at some employers. Reuters reported that Cigna ended coverage of GLP-1 weight-loss drugs in its own employee health plan from July 1, 2026, and pointed current users to cash-pay options.

If your employer plan excludes coverage, see your cash-pay and savings-card options

Compare Savings Routes →

What actually moves an exclusion

If your plan’s exclusion is confirmed, here’s what has a realistic chance of changing it, and what doesn’t:

A clinical appeal won’t work. Appealing to your insurer’s medical director doesn’t help when the problem is a benefit design decision, not a medical necessity determination. Save that effort for an actual coverage restriction, not an exclusion.
HR and your benefits committee are the actual decision-makers. For a self-funded plan, your employer chooses what to cover at each plan-year renewal, often advised by a benefits consultant and a pharmacy benefit manager. Raising the issue with HR, ideally with other employees or through an employee resource group, is a real (if slow) lever, because employers do weigh cost against retention and recruiting pressure.
Open enrollment is the checkpoint. Coverage decisions typically get revisited once a year. If HR says “we’re reviewing it for next year,” that’s a genuine signal worth following up on at the next enrollment period, not a brush-off.
A cash-pay or savings-card route fills the gap in the meantime. Our savings comparison guide covers manufacturer self-pay offers and patient assistance programs, and our TrumpRx pricing guide covers the newer cash-price referral option. Both exist independently of what your employer’s plan covers.

Bottom Line

If your employer plan excludes GLP-1 coverage outright, that’s a benefit design choice, usually made possible by the fact that most large employers self-fund their plans and state insurance mandates generally don’t reach self-funded plans under federal ERISA law. The one state mandate we found, North Dakota’s, covers only individual and small-group plans. Confirm whether you’re dealing with an outright exclusion or a fixable coverage restriction before you spend time on an appeal, since only the second one responds to one. If it’s a true exclusion, your realistic options are pushing through HR ahead of the next open enrollment or using a manufacturer savings card, patient assistance program, or cash-pay route in the meantime.

FAQ

Can I appeal my employer’s decision to exclude GLP-1s from coverage?

Not through a clinical or medical appeal. A plan exclusion is a benefit design decision made by your plan sponsor, typically your employer for a self-funded plan, and it isn’t something a doctor’s letter of medical necessity can override. The only real lever is raising it with HR or your benefits committee ahead of the next plan-year renewal.

Does my state’s GLP-1 coverage law apply to my employer’s plan?

Probably not, for two separate reasons. First, the only state mandate we found, North Dakota’s, applies to individual and small-group plans, not large-group plans. Second, even where states have tried, federal ERISA law generally exempts self-funded employer plans from state insurance mandates, and most large-employer workers are on self-funded plans.

How do I know if my plan is self-funded?

Ask your HR or benefits team directly, or check your plan’s summary plan description for funding language. A familiar insurer’s name on your card doesn’t tell you this. Insurers administer both fully insured and self-funded plans, and for a self-funded plan, that insurer is just the claims processor, not the risk-bearer.

Is it worth bringing up weight-based discrimination law with my employer?

It’s worth knowing it exists, but it’s not a reliable lever. A few states and cities, including Michigan, Washington and New York City, have weight-based non-discrimination laws. Whether they reach a health plan’s drug exclusion is unsettled, and they are not an established right to coverage.

Guides:

Compare: All Providers · All Guides

What we checked

This AI-assisted public-source desk check reviewed the KFF 2025 Employer Health Benefits Survey, the North Dakota Insurance Department’s announcement, reporting on North Carolina’s State Health Plan, a law-firm summary of New York City’s weight discrimination law, Business Group on Health survey coverage, Mercer’s June 2026 release and Reuters reporting on Cigna on November 4, 2026. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.